Cassava Sciences SAVA recently suffered yet another setback, which raises concern regarding its prospects. Last week, the company announced that the phase III study REFOCUS-ALZ on lead pipeline ...
A downtrend has been apparent in Cassava Sciences, Inc. (SAVA) lately with too much selling pressure. The stock has declined 83.9% over the past four weeks. However, given the fact that it is now in ...
Cassava Sciences Inc (NASDAQ:SAVA) shares are trading higher Tuesday morning after a Form 4 filing disclosed that CEO Rick Barry acquired 237,941 shares at an average price of $2.25 each. What To Know ...
I love SAVA’s concept— curated cannabis. It means something to me to learn from others. I don't know everything, far from. So, when I discovered the "curated" approach that SAVA takes, they certainly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback